U S Physical Therapy INC /NV Form 4 insider transactions
NYSE
Director Bernard A. Harris Jr. receives 1,882 shares of restricted stock in U.S. Physical Therapy, Inc.
NYSE
Director Clayton Trier reports acquisition of 1,882 shares of restricted stock in U.S. Physical Therapy, Inc.
NYSE
Director Nancy Ham acquired 1,882 shares of restricted stock in U.S. Physical Therapy, Inc., with vesting occurring over the next year.
NYSE
Regg E. Swanson, a director of U.S. Physical Therapy, Inc., acquired 1,882 shares of restricted stock and holds a total of 13,186 shares directly and 7,596 indirectly through a trust.
NYSE
Carey Hendrickson, CFO of U.S. Physical Therapy, reports the disposal of common stock and provides details on remaining holdings and vesting schedules.
NYSE
Graham Reeve, COO of U.S. Physical Therapy, sold 1,730 shares of common stock at $82.11 and reported the vesting schedule of 19,192 restricted shares.
NYSE
Carey Hendrickson, CFO of U.S. Physical Therapy, reports the acquisition of 8,100 shares of common stock and amended vesting terms for outstanding awards.
NYSE
Graham D. Reeve, COO of U S Physical Therapy Inc, received 8,100 shares of restricted stock and agreed to amended vesting terms for outstanding unvested shares.
NYSE
Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy, acquired shares of common stock and amended the vesting terms of outstanding awards.
NYSE
Eric Joseph Williams, President and COO of U.S. Physical Therapy Inc., received 12,150 shares of restricted stock and amended the vesting terms of existing unvested shares.
NYSE
Christopher J. Reading, Chairman and CEO of U.S. Physical Therapy Inc., received a grant of 20,250 shares of restricted stock and an amendment to the vesting terms of existing unvested shares.
NYSE
Carey P. Hendrickson, CFO of U.S. Physical Therapy Inc., sold 516 shares of common stock at $96.25 per share and disclosed a vesting schedule for restricted stock grants.
NYSE
Richard Binstein, EVP Gen'l Counsel & Secretary at U.S. Physical Therapy, sold 1,128 shares of common stock at $98.52 per share on November 25, 2024.
NYSE
Bernard A. Harris Jr., a director at U.S. Physical Therapy Inc., sold 2,000 shares of common stock at an average price of $92.95 per share.
NYSE
Nancy Ham, a director at U.S. Physical Therapy Inc., sold 1,172 shares of common stock at an average price of $96.72 on November 8, 2024.
NYSE
Graham D. Reeve, COO of U.S. Physical Therapy, sold 1,724 shares of common stock at $96.29 per share, while still holding a substantial amount of shares directly and indirectly.
NYSE
Eric Joseph Williams, Co-Chief Operations Officer of U.S. Physical Therapy Inc., sold 2,000 shares of common stock at a weighted average price of $95.84.
NYSE
Clayton Trier, a director at U.S. Physical Therapy Inc., sold 2,000 shares of common stock at an average price of $95.78.
NYSE
Kathleen Gilmartin, a director of U.S. Physical Therapy, recently purchased 2,000 shares of the company's common stock at an average price of $86.09.
NYSE
Graham Reeve, COO of U.S. Physical Therapy Inc., reports the sale of 1,724 shares of common stock at a weighted average price of $82.50.
NYSE
Christopher Reading, Chairman and CEO of U.S. Physical Therapy, sold 2,900 shares of common stock at an average price of $100.26 on May 30, 2024.
NYSE
Christopher Reading, Chairman and CEO of U.S. Physical Therapy, Inc., reports the sale of company stock in two transactions.
NYSE
Director Regg E. Swanson acquired 1,424 shares of restricted stock in U.S. Physical Therapy Inc. on May 20, 2024, and beneficially owns 11,304 shares directly and 7,596 shares indirectly through a trust.
NYSE
Director Anne Motsenbocker reports acquisition of 1,424 shares of restricted stock in U.S. Physical Therapy Inc.
NYSE
Director Bernard A. Harris Jr. acquired 1,424 shares of U.S. Physical Therapy Inc. as part of the company's Amended and Restated 2003 Stock Incentive Plan.
NYSE
Director Kathleen A. Gilmartin reports acquisition of 1,424 shares of restricted stock in U.S. Physical Therapy Inc.
NYSE
Form 4: U.S. Physical Therapy Director Clayton Trier Acquires Shares as Part of Stock Incentive Plan
Clayton Trier, a director at U.S. Physical Therapy, acquired 1,424 shares of common stock as part of the company's Amended and Restated 2003 Stock Incentive Plan.
NYSE
Carey Hendrickson, CFO of U.S. Physical Therapy, reported a gift of shares, resulting in a slightly reduced beneficial ownership.
NYSE
Director Nancy Ham reports acquisition of 1,424 shares of restricted stock in U.S. Physical Therapy Inc.
NYSE
Richard Binstein, EVP, General Counsel & Secretary of U.S. Physical Therapy, sold 2,111 shares of common stock at an average price of $106.34 on May 16, 2024.